Trial Profile
Pharmacokinetics of 20 mg BF2.649 in Single Dose, in Subjects With Normal Renal Function Compared to Subject With Impaired Renal Function
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Pitolisant (Primary)
- Indications Sleep disorders
- Focus Pharmacokinetics
- 19 Jun 2012 New trial record